ABBV vs HUM
By Alex · Tickerpine
AbbVie Inc. vs Humana Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | HUM |
|---|---|---|
| Price | $285.64 | $422.07 |
| Market cap | $504.76B | $50.68B |
| P/E ratio | 80.5 | 39.9 |
| ROE | — | 6.89% |
| Profit margin | 9.80% | 0.88% |
| Revenue growth | 10.20% | 26.20% |
| Dividend yield | 2.42% | 0.84% |
| Beta | 0.23 | 0.74 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs HUM in plain English
- ABBV is the bigger company — about 10.0× the market cap of HUM.
- HUM is cheaper on earnings (P/E 39.9 vs 80.5).
- HUM is growing revenue faster (26% vs 10%).
- ABBV has the higher dividend yield (2.42% vs 0.84%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
HUM return calculator
See what $1,000 in Humana Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.